Array Bio (ARRY) was downgraded to neutral from overweight at JPMorgan. The valuation is less attractive, based on a $10 price target.
Parexel (PRXL) was downgraded to sell from hold at Deutsche Bank. $53 price target. The company can't cut costs fast enough to offset lower sales, Deutsche said.
Quintiles (Q) was downgraded to hold from buy at Deutsche Bank. $80 price target. The valuation is less attractive, given concern around sales growth from the merger, Deutsche said.